Clinical Trial Update: Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating vaccine therapy with or without sargramostim and with or without docetaxel in patients with metastatic lung cancer or metastatic colore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Small Cell Lung Cancer, Recurrent Colon Cancer | Phase 1 | Status: TERMINATED